- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Bolt Biotherapeutics Prices Upsized Initial Public Offering The post Press Release appeared first on Bolt Biotherapeutics.
Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte The post Press Release appeared first on Bolt Biotherapeutics.
Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting The post Press Release appeared first on Bolt Biotherapeutics.
Data Published in Nature Cancer Highlight Preclinical Proof of Concept of Bolt Biotherapeutics’ Boltbody™ ISAC Platform The post Press Release appeared first on Bolt Biotherapeutics.
Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm Business of Biotech Podcast The post Podcast appeared first on Bolt Biotherapeutics.
Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting The post Press Release appeared first on Bolt Biotherapeutics.
Bolt Biotherapeutics Closes $93.5 Million Series C Financing The post Press Release appeared first on Bolt Biotherapeutics.
CMC Considerations For In-Human Studies with Drs. Edith Perez and Nathan Ihle Business of Biotech Podcast The post Podcast appeared first on Bolt Biotherapeutics.
Randy Schatzman, PhD, CEO of Bolt Biotherapeutics Biotech 2050 Podcast The post Podcast appeared first on Bolt Biotherapeutics.
Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs Xconomy The post Media Coverage appeared first on Bolt Biotherapeutics.
